Status of Fresenius Kabi/Akorn Acquisition drugs

Subject: Status of Fresenius Kabi/Akorn Acquisition
To: communications.USA {at} fresenius-kabi.com
From: Rich Jones <rich {at} pubmail.io>
On: Oct. 26, 2017, 6:13 p.m.

Hello, my name is Rich Jones, I'm a reporter seeking a statement about the statue of the Fresenius-Kabi acquisition of Akorn Pharmaceuticals given news of today's arrest of Akorn chairman John Kapoor.

Will the acquisition still take place? Will John Kapoor remain on the staff?

Thank you,
Rich Jones